Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
Atezolizumab + Cabozantinib for Pancreatic Cancer
Recruiting1 awardPhase 2
Tucson, Arizona
This trial is testing a combination of two drugs to treat pancreatic cancer. The drugs will be given to patients with cancer that has spread and who have not responded to other treatments. The goal is to see if the combination is safe and works better than other treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service